Broadridge Financial Solutions Other Income (Expense) decreased by 96.7% to $6.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 321.4%, from -$2.80M to $6.20M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -53.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.80M | -$2.40M | $4.40M | -$2.70M | -$2.30M | -$5.20M | -$1.90M | $1.80M | -$700.00K | -$2.10M | -$400.00K | -$900.00K | -$1.90M | -$1.90M | -$2.80M | -$500.00K | $48.50M | $188.00M | $6.20M |
| QoQ Change | — | -103.3% | +283.3% | -161.4% | +14.8% | -126.1% | +63.5% | +194.7% | -138.9% | -200.0% | +81.0% | -125.0% | -111.1% | +0.0% | -47.4% | +82.1% | >999% | +287.6% | -96.7% |
| YoY Change | — | — | — | — | -103.2% | -116.7% | -143.2% | +166.7% | +69.6% | +59.6% | +78.9% | -150.0% | +9.5% | -375.0% | -211.1% | — | >999% | >999% | +321.4% |